November 18th 2024
AHA 2024. Findings from the BPROAD trial help fill a gap left by similar studies on the ideal target SBP for adults with type 2 diabetes, said study authors.
November 15th 2024
Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.
September 27th 2024
Your daily dose of the clinical news you may have missed.
September 25th 2024
September 17th 2024
New data shows that favorable CV health in the first trimester is associated with a 35% to 62% lower risk of HDP regardless of level of genetic risk.
Daily Dose: Efficacy of a Remote Bilingual Program in Reducing Uncontrolled HTN
Antihypertensive Treatment Throughout Late Life May Reduce Risk of Dementia
Results from a new study show that older adults with untreated hypertension had a 42% increased risk of dementia vs healthy controls.
Daily Dose: High Blood Pressure While Lying Down Raises Risk for CVD Events
Blood Pressure Treatment Targets in Adults with Hypertension: A Guideline Topline
This guideline topline summary of recommendations for treating hypertension in adults is adapted from the American Academy of Family Physicians clinical guideline.
Lorundrostat Phase 2 Trial Results Suggest Potential Efficacy Against Uncontrolled and Resistant Hypertension
The selective aldosterone synthase inhibitor will move into late stage clinical trials, a nod to the potential for a first-in-class agent targeting aldosterone.
Remote Bilingual Program Proves Effective in Controlling Blood Pressure in Underserved Population
New research presented at Hypertension 2023 showed a novel digital bilingual hypertension control program improved BP control rates by more than 30%.
Hypertension While Lying Down Linked to Elevated Risk for CVD Events
Persons with HTN while in a supine position had a higher risk for CVD even if they did not have HTN while seated, according to new research presented at Hypertension 2023.
NIH Designates Centers of Excellence to Improve Maternal Health Equity
The newly named centers across the country will work closely with communities to focus research on populations at greatest risk for perinatal morbidity and mortality.
Patients with COVID-19 More Likely to Develop Hypertension than Those with Influenza, Shows New Study
Patients hospitalized with COVID-19 were 2-times more likely to develop persistent hypertension than their influenza counterparts, according to results.
Social Determinants of Health Drive CVD Mortality Differences Between Black and White Adults
Excess CVD mortality among Black vs White adults was diminished after control for behavior/metabolic factors and negligible after adjustments for SDOH, a new study reveals.
Daily Dose: Effects of Cuff Size on Accuracy of BP Readings
A daily dose of clinical news on Patient Care you may have missed.
Expert Details the Top 3 CV Complications Seen in Patients with Obesity
Internist and obesity medicine specialist Alina Elperin, MD, details the most common cardiovascular complications that she has observed in patients with obesity.
For Accurate BP Measurement, Cuff Size Must Be "Just Right"
Blood pressure cuffs that are too large or too small for an individual's upper arm return measurements that may misguide therapeutic decisions, say study authors.
Daily Dose: Regular Alcohol Intake Raises Risk of High Blood Pressure
Drinking Even 1 Alcoholic Beverage per Day May Increase Risk for Hypertension, Study Finds
The association between ETOH consumption and hypertension among 19 500 healthy adults was "direct and linear," a new dose-response meta-analysis found.
Daily Dose: Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders
Social Determinants of Health and Prevention of Cardiovascular Disease
Methods proven to prevent ASCVD may fall short in certain populations if the impacts of SDOH are not closely monitored. The ACC/AHA provide considerations for 7 health domains.
Distinct Patterns of BP in Early Gestation Predict Hypertensive Disorders: Study
Investigators identified 6 blood pressure patterns that, when combined with other risk factors, accurately stratified risk of hypertensive disorders of pregnancy.
Inclisiran Label Expanded to Include Primary Prevention Population
The expanded indication widens the patient population eligible for the novel siRNA therapy to include high-risk patients on maximum statin Rx who have not had a CV event.
Home Blood Pressure Monitoring among Older US Adults
Among adults aged 50 to 80 years with a BP-related condition, less than half say they regularly monitor BP at home; one-third are "not very concerned" about their BP.
Daily Dose: Postmenopausal Women Using Oral Estrogen Hormone Therapy More Likely to Develop HTN
Your daily dose of clinical news you may have missed.
Risk of Hypertension in Postmenopausal Women Higher with Oral Estrogen-only Hormone Therapy
Oral estrogen hormone therapy was more likely to result in incident hypertension than transdermal or vaginal formulations in this large prospective population-based study.
Friday's 5 Quotes for Primary Care 4-21-2023
Statins in AF patients cut risk of TIA; opioid makers must strengthen label warnings; individualized Rx reduces BP; and 2 more research quotes of note.
Daily Dose: Heterogeneity in BP Response to Antihypertensive Medications
Personalized Treatment Found to Result in Greater Reductions in Blood Pressure in New Study
Results showed that on average, personalized treatment choice had the potential to provide an additional 4.4 mm Hg-lower systolic blood pressure.
Friday's 5 Quotes for Primary Care - 4-7-2023
High salt intake linked to coronary atherosclerosis; daily ETOH, even in small doses, is dangerous; statins don't increase muscle injury; and 2 more studies of note.
Sodium Intake Shows Strong Linear Relationship with Risk of Both Carotid and Coronary Atherosclerosis: Population-based Study
Each 1000 mg rise in Na excretion saw a corresponding 3%, 4%, and 4% higher risk of worsening carotid plaque, CAC score, and coronary artery stenosis, respectively.
Daily Dose: Pediatric Primary Hypertension
Primary Hypertension in Children and Adolescents “Underrecognized,” According to New AHA Scientific Statement
Pediatric hypertension and the need for appropriate diagnosis, treatment, and reduction of lifestyle risk factors outlined in new scientific statement.
FDA Proposed Rule Change Expands Use of Salt Substitutes to Lower NaCl Intake, Reduce Chronic Disease
The rule change would provide flexibility in standards that govern specific ingredients used in food production, permitting replacement of regular sodium with less toxic substitutes.